Stanford University
Showing 201-220 of 1,705 Results
-
Yifan Gao
Postdoctoral Scholar, Microbiology and Immunology
BioDr. Yifan Gao is a postdoctoral researcher at Stanford University School of Medicine in the Department of Microbiology and Immunology under Prof. Justin Sonnenburg's advisement. Prior to joining Stanford, she received her Ph.D. from UCLA focusing on Environmental Microbiology and M.S. from UC Berkeley in Environmental Engineering.
-
Adrené Garabedian
Engagement Programs Manager, Emergency Medicine
Current Role at StanfordEmergency Medicine Strategy Manager
Faculty & Staff Engagement Program Manager & Co-Lead -
Lorenza Garau Paganella
Postdoctoral Scholar, Mechanical Engineering
BioLorenza was born in Italy in 1997 and is currently a postdoctoral fellow at Stanford University with Prof. Chaudhuri, supported by an SNSF fellowship. Her research focuses on engineering biomaterials to investigate cell–extracellular matrix interactions and mechanotransduction in 2D and 3D cell cultures, aiming to advance biomedical understanding of tissue remodeling and disease.
Lorenza obtained her PhD (2024) in Mechanical and Process Engineering from ETH Zurich, where she developed hydrogel scaffolds and protocols for protein isolation to study cell behavior in engineered microenvironments.
Before her PhD, Lorenza completed her MSc at ETH Zurich and BSc at University of Trieste in Process Engineering, graduating both cum laude. During this time her focus was on biomaterials for drug delivery which she complemented with an internship in Roche. She has worked in interdisciplinary teams combining engineering and biology and is motivated by research that bridges fundamental science with clinical impact. -
Zainab Garba-Sani
Affiliate, Health Policy
BioZainab Garba-Sani is a Stanford-affiliated Research Scholar and UK Commonwealth Fund Senior Harkness Fellow (2022–23), working at the intersection of health policy, science, and community-centred practice. Her work focuses on how emerging fields such as artificial intelligence, genomics, and regenerative medicine can be translated responsibly into real-world health impact - particularly for underserved populations and people living with chronic and rare conditions.
Her research and practice are grounded in bridging cutting-edge science and innovation with lived experience - focusing on inclusive design, governance, and real-world implementation. She is the founder of ACCESS AI, an initiative advancing equitable and inclusive approaches to health AI through diverse community engagement, meaningful co-production, and interdisciplinary collaboration. Through this work, she contributes to broader conversations on AI governance, data equity, and the societal implications of innovation.
Alongside this, Garba-Sani collaborates internationally with academic institutions, healthcare systems, civil society, industry, and governments to strengthen innovation pathways and care models for sickle cell and other historically neglected populations, including in low-and middle- income countries. She holds senior advisory and leadership roles across health and research ecosystems and is an advisor to multiple committees focused on gene and cell therapies, regenerative medicine, health equity, and rare diseases. She is Vice Chair of the Sickle Cell Society and was recently the Founding Chair of NHS England’s Sickle Cell Transformation Patient Advisory Group and Co-Chair of Genomics England’s Diverse Data Advisory Board.
Garba-Sani holds an MSc in Health Policy from Imperial College London and brings extensive experience in healthcare leadership, having previously served in senior roles at NHS England, TEDxNHS, and the NHS Muslim Network. Her contributions have been recognised with numerous awards, including the UK Prime Minister’s Points of Light Award. -
Alan M. Garber
Henry J. Kaiser Jr. Professor and Professor of Medicine, Emeritus
Current Research and Scholarly InterestsTopics in the health economics of aging; health, insurance; optimal screening intervals; cost-effectiveness of, coronary surgery in the elderly; health care financing and delivery, in the United States and Japan; coronary heart disease
